S. Nicole Hastings

Nov 29, 2024 | agsjournals.onlinelibrary.wiley.com | Sascha Dublin |Juliessa M. Pavon |S. Nicole Hastings |Ladia Albertson-Junkans

CONFLICT OF INTEREST STATEMENT SD has received funding from GSK. SH has consulted for or received funding from Pfizer, Johnson & Johnson, Novo Nordisk, Arbor Pharmaceuticals, the Medullary Thyroid Cancer Consortium (Novo Nordisk, AstraZeneca, GlaxoSmithKline, and Eli Lilly), Biogen, Intercept Pharmaceuticals, Provention Bio, bluebird bio, and Amylyx Pharmaceuticals.

Nov 2, 2023 | agsjournals.onlinelibrary.wiley.com | Audrey D. Zhang |Timothy Anderson |S. Nicole Hastings

INTRODUCTION Over 6.5 million Americans are estimated to live with Alzheimer disease, which disproportionately affects women and members of the Black and Hispanic communities.1 Despite the significant burden of Alzheimer disease, only recently have drugs intended to slow Alzheimer disease progression entered the market.